Molecular Stethoscope
San Diego, US · Founded 2015 · Delaware corporation · 2 known investors
Founders & leadership
GM
Guillermo M. Elias, Ph.D.Executive
SQ
Stephen Quake, D. Phil.Named on SEC filing
Board
AM
Arda Minocherhomjee, Ph.D.Board director
TS
Tina S. Nova, Ph.D.Board director
Investors · 2
Reported raises · per SEC filings
Form D private placements$4.5M disclosed across 1 round · 2019
▶$4.5MraisedOct 2019 · 15 investors · BiotechnologyRule 506(b)
▶$4.5MraisedOct 2019 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stephen Quake, D. Phil.Director
- Guillermo M. Elias, Ph.D.Executive Officer
- Arda Minocherhomjee, Ph.D.Director
- Tina S. Nova, Ph.D.Director
- Offering amount
- $5.6M
- Amount sold
- $4.5M
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Molecular Stethoscope's investors?
- Molecular Stethoscope's investors include AAF Management Ltd., DCVC (Data Collective).
- How much funding has Molecular Stethoscope raised?
- Molecular Stethoscope has disclosed $4.5M raised across 1 round.
- Where is Molecular Stethoscope headquartered?
- Molecular Stethoscope is headquartered in San Diego, US.